Skip to content

Visual Outcomes of Vivity in Patients With High Axial Length

Visual Outcomes of the AcrySof® Vivity Intraocular Lens in Patients With High Ocular Axial Length

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05210569
Enrollment
20
Registered
2022-01-27
Start date
2022-01-13
Completion date
2023-09-06
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

EDOF IOL Vivity

Brief summary

The objective is to assess the visual outcomes and quality of vision of patients receiving the AcrySof® Vivity Intraocular lens (IOL), when implanted in eyes with high ocular axial length (≥24.5mm), after uneventful cataract surgery.

Detailed description

This study is a single-arm unmasked clinical evaluation study of binocular uncorrected visual acuity at distance (6m), intermediate (66cm) and near (40cm), when implanted in eyes with high ocular axial length (≥24.5mm), after successful bilateral cataract surgery. Subjects will be assessed preoperatively, operatively, and at 1 day, 1 week, 1 month, and 3 months postoperatively. Clinical evaluations will include administration of a visual disturbance questionnaire (QUVID) and a satisfaction questionnaire (IOLSAT), as well as measurement of binocular and monocular visual acuities and manifest refraction.

Interventions

DEVICEVivity

Vivity intraocular lens (IOL)

Sponsors

Sengi
CollaboratorINDUSTRY
Dr. James J. Wiens Medical Corporation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. Inclusion Criteria: * Undergoing uncomplicated bilateral cataract surgery with IOL implantation. * Gender: Males and Females. * Age: 50 years or older. * Willing and able to provide written informed consent for participation in the study. * Willing and able to comply with scheduled visits and other study procedures. * Motivated for greater degree of spectacle independence vs monofocal IOL. * Axial length ≥24.5mm in both eyes. * Planned cataract removal by femtosecond laser.

Exclusion criteria

If any of the following

Design outcomes

Primary

MeasureTime frameDescription
Binocular Uncorrected Distance Visual Acuity (logMAR)3 months postoperativelyBinocular uncorrected distance visual acuity (logMAR)
Binocular Uncorrected Intermediate Visual Acuity (logMAR)3 months postoperativelyBinocular uncorrected intermediate visual acuity (logMAR)
Binocular Uncorrected Near Visual Acuity (logMAR)3 months postoperativelyBinocular uncorrected near visual acuity (logMAR)

Secondary

MeasureTime frameDescription
Binocular Distance Corrected Intermediate Visual Acuity (logMAR)3 months postoperativelyBinocular distance corrected intermediate visual acuity (logMAR)
Binocular Distance Corrected Near Visual Acuity (logMAR)3 months postoperativelyBinocular distance corrected near visual acuity (logMAR)
Monocular Corrected Distance Visual Acuity (logMAR)3 months postoperativelyMonocular corrected distance visual acuity (logMAR)
Monocular Distance Corrected Intermediate Visual Acuity (logMAR)3 months postoperativelyMonocular distance corrected intermediate visual acuity (logMAR)
Binocular Distance-corrected Low Contrast Distance Visual Acuity (logMAR)3 months postoperativelyBinocular distance-corrected low contrast distance visual acuity (logMAR)
Manifest Refraction Spherical Equivalent3 months postoperativelyManifest refraction spherical equivalent
Questionnaire3 months postoperativelyQuestionnaire for visual disturbance scores (QUVID)
Percentage of Participants With Spectacle Independence3 monthsThe Intraocular Lens Satisfaction questionnaire (IOLSAT). Subjects were asked how often they needed to wear eyeglasses to see at distance, intermediate, and near. The percentage was calculated as (# of subjects responding Never or Rarely) divided by (# of subjects) times 100. A higher percentage is a better outcome.
Monocular Distance Corrected Near Visual Acuity (logMAR)3 months postoperativelyMonocular distance corrected near visual acuity (logMAR)
Prediction Error3 months postoperativelyPercentage of eyes with absolute prediction error of 0.5D or less
Binocular Corrected Distance Visual Acuity (logMAR)3 months postoperativelyBinocular corrected distance visual acuity (logMAR)

Countries

Canada

Participant flow

Participants by arm

ArmCount
Bilateral Implantation of the Vivity IOL
Vivity intraocular lens (IOL) Vivity: Vivity intraocular lens (IOL)
20
Bilateral Implantation of the Vivity IOL
Vivity intraocular lens (IOL) Vivity: Vivity intraocular lens (IOL)
40
Total60

Baseline characteristics

CharacteristicBilateral Implantation of the Vivity IOL
Age, Continuous65.7 years
STANDARD_DEVIATION 6.5
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Binocular Uncorrected Distance Visual Acuity (logMAR)

Binocular uncorrected distance visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Uncorrected Distance Visual Acuity (logMAR)-0.1 logMARStandard Deviation 0.06
Primary

Binocular Uncorrected Intermediate Visual Acuity (logMAR)

Binocular uncorrected intermediate visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Uncorrected Intermediate Visual Acuity (logMAR)0.01 logMARStandard Deviation 0.08
Primary

Binocular Uncorrected Near Visual Acuity (logMAR)

Binocular uncorrected near visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Uncorrected Near Visual Acuity (logMAR)0.21 logMARStandard Deviation 0.11
Secondary

Binocular Corrected Distance Visual Acuity (logMAR)

Binocular corrected distance visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Corrected Distance Visual Acuity (logMAR)-0.14 logMARStandard Deviation 0.06
Secondary

Binocular Distance Corrected Intermediate Visual Acuity (logMAR)

Binocular distance corrected intermediate visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Distance Corrected Intermediate Visual Acuity (logMAR)-0.02 logMARStandard Deviation 0.06
Secondary

Binocular Distance-corrected Low Contrast Distance Visual Acuity (logMAR)

Binocular distance-corrected low contrast distance visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Distance-corrected Low Contrast Distance Visual Acuity (logMAR)0.05 logMARStandard Deviation 0.08
Secondary

Binocular Distance Corrected Near Visual Acuity (logMAR)

Binocular distance corrected near visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLBinocular Distance Corrected Near Visual Acuity (logMAR)0.18 logMARStandard Deviation 0.1
Secondary

Manifest Refraction Spherical Equivalent

Manifest refraction spherical equivalent

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLManifest Refraction Spherical Equivalent0.25 diopter (D)Standard Deviation 0.37
Secondary

Monocular Corrected Distance Visual Acuity (logMAR)

Monocular corrected distance visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLMonocular Corrected Distance Visual Acuity (logMAR)-0.09 logMARStandard Deviation 0.05
Secondary

Monocular Distance Corrected Intermediate Visual Acuity (logMAR)

Monocular distance corrected intermediate visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLMonocular Distance Corrected Intermediate Visual Acuity (logMAR)0.05 logMARStandard Deviation 0.09
Secondary

Monocular Distance Corrected Near Visual Acuity (logMAR)

Monocular distance corrected near visual acuity (logMAR)

Time frame: 3 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Bilateral Implantation of the Vivity IOLMonocular Distance Corrected Near Visual Acuity (logMAR)0.32 logMARStandard Deviation 0.15
Secondary

Percentage of Participants With Spectacle Independence

The Intraocular Lens Satisfaction questionnaire (IOLSAT). Subjects were asked how often they needed to wear eyeglasses to see at distance, intermediate, and near. The percentage was calculated as (# of subjects responding Never or Rarely) divided by (# of subjects) times 100. A higher percentage is a better outcome.

Time frame: 3 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Bilateral Implantation of the Vivity IOLPercentage of Participants With Spectacle IndependenceSpectacle independence distance (overall)19 Participants
Bilateral Implantation of the Vivity IOLPercentage of Participants With Spectacle IndependenceSpectcle independence intermediate (overall)18 Participants
Bilateral Implantation of the Vivity IOLPercentage of Participants With Spectacle IndependenceSpectacle independence near (overall)8 Participants
Secondary

Prediction Error

Percentage of eyes with absolute prediction error of 0.5D or less

Time frame: 3 months postoperatively

ArmMeasureValue (COUNT_OF_UNITS)
Bilateral Implantation of the Vivity IOLPrediction Error35 Eyes
Secondary

Questionnaire

Questionnaire for visual disturbance scores (QUVID)

Time frame: 3 months postoperatively

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by double vision0 Participants
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by starbursts2 Participants
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by halos0 Participants
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by glare2 Participants
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by haze1 Participants
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by blurred vision0 Participants
Bilateral Implantation of the Vivity IOLQuestionnaireBothered quite a bit or Bothered very much by dark area0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026